It was believed that GPR56 promoted drug resistance of CRC by upregulating multidrug resistance protein 1 (MDR1) expression via a RhoA-dependent signaling pathway [90] (Table 1). The gene discussed is ADGRG1; the disease is colorectal carcinoma.